BioMarin Pharmaceutical Inc (BMRN) Free cash flow 2016–2025
BioMarin Pharmaceutical Inc (BMRN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$725.0MFY2025 · since FY2016: -$376.2M → $725.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $725.0M | +48.7% |
| FY2024 | $487.4M | +679.0% |
| FY2023 | $62.6M | +13.9% |
| FY2022 | $54.9M | -73.7% |
| FY2021 | $209.0M | +821.9% |
| FY2020 | -$28.9M | +70.1% |
| FY2019 | -$96.8M | +22.2% |
| FY2018 | -$124.4M | +40.2% |
| FY2017 | -$208.0M | +44.7% |
| FY2016 | -$376.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice